- $20.26m
- $16.12m
- $22.03m
Brief: Lifeward To Acquire Powered Upper Body Exoskeleton With Ai Capabilities
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 08:30 AM
Brief: Oramed And Lifeward Announce Strategic Transaction
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
Brief: Lifeward Appoints Bob Marshall As Chairman Of The Board
Brief: Lifeward Reports Second Quarter 2025 Financial Results
Brief: Lifeward Expands Partnership With Sportsmed to Cover UAE and Entire Gorperation Council Region
Brief: Medrhythms Appoints Larry Jasinski As Chief Executive Officer
Brief: Lifeward Announces Closing Of $2.6 Million Public Offering
Brief: Lifeward Announces Pricing Of $2.6 Million Public Offering
CEO Larry Jasinski To Resign From Board Effective June 30, 2025 - SEC Filing
On June 2, Michael Lawless Resigned As CFO Of Lifeward - SEC Filing
Brief: Lifeward Ltd Files For Mixed Shelf Of Up To $100 Million
Brief: FDA Issues Clearance For Rewalk 7 Exoskeleton
Lifeward soars on FDA nod for exoskeleton device
Brief: Lifeward Streamlines US Operations In Next Phase Of Growth And Operational Efficiencies